|
Medical Oncology Divisional Updates Part 1 |
10/08/2025 - 8:00am to 9:00am EDT |
|
Medical Oncology Divisional Updates Part 2 |
10/15/2025 - 8:00am to 9:00am EDT |
|
The Imperative for Outcomes Research: 2026 and Beyond |
10/22/2025 - 8:00am to 9:00am EDT |
|
Citrullinated Vimentin is an Effective Target for CAR T Cells in Solid Tumors/Healthcare Delivery & Outcomes Research in Myeloid Malignancies |
10/29/2025 - 8:00am to 9:00am EDT |
|
Drugging the Undruggable: KRAS Inhibition in Pancreatic Cancer / “Just A Reminder” The potential gloom of myeloma longevity |
11/05/2025 - 8:00am to 9:00am EST |
|
The aging immune system and T-cell mediated immunotherapy / Updates on the treatment landscape of small cell lung cancer |
11/12/2025 - 8:00am to 9:00am EST |
|
Chromatin and Cancer: From Mechanisms to Emerging Therapies |
11/19/2025 - 8:00am to 9:00am EST |
|
HEMATOLOGY ONCOLOGY GRAND ROUNDS 2025 |
11/26/2025 - 8:00am to 9:00am EST |
|
A difficult balance: a case of pregnancy in metastatic breast cancer/Frequency, characterization, and clinical impact of unexpected cardiac and extracardiac imaging findings in premenopausal women on the CROWN study |
12/03/2025 - 8:00am to 9:00am EST |
|
PSMA PET in Biochemically Recurrent Prostate Cancer/EGFR in NSCLC: Front-line, Progression, and Finding New Targets for Resistant Disease |
12/10/2025 - 8:00am to 9:00am EST |
Facebook
X
LinkedIn
Forward